UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanical hyperalgesias in neuropathic pain patients: Dynamic and static subtypes

Annals of neurology, 1993-05, Vol.33 (5), p.465-472

1993

Volltextzugriff (PDF)

Neuropathic pain: redefinition and a grading system for clinical and research purposes

Neurology, 2009-04, Vol.72 (14), p.1282-1283

Ochoa, Jose L

2009

Volltextzugriff (PDF)

'Sympathetically maintained pain.' I. Phentolamine block questions the concept

Neurology, 1994-06, Vol.44 (6), p.1003-1003

1994

Volltextzugriff (PDF)

Phentolamine sympathetic block in painful polyneuropathies. II. Further questioning of the concept of 'sympathetically maintained pain'

Neurology, 1994-06, Vol.44 (6), p.1010-1010

1994

Volltextzugriff (PDF)

Reversal of hypoaesthesia by nerve block, or placebo: a psychologically mediated sign in chronic pseudoneuropathic pain patients

Journal of neurology, neurosurgery and psychiatry, 1998-08, Vol.65 (2), p.196-203

1998

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors

Clinical cancer research, 2005-12, Vol.11 (24), p.8728-8736

2005

Volltextzugriff (PDF)

Teclistamab Induces Favorable Responses in Patients with Relapsed and Refractory Multiple Myeloma after Prior BCMA-Directed Therapy

Blood, 2023-11, Vol.142 (Supplement 1), p.3351-3351

2023

Volltextzugriff (PDF)

Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning Results in Favorable Outcomes with Haploidentical Donor Peripheral Blood Stem Cell Transplant

Blood, 2023-11, Vol.142 (Supplement 1), p.4900-4900

2023

Volltextzugriff (PDF)

Post-Transplant Cyclophosphamide Equalizes Clinical Outcomes of Allogeneic Hematopoietic Cell Transplantation across Racial and Ethnic Populations

Blood, 2023-11, Vol.142 (Supplement 1), p.390-390

2023

Volltextzugriff (PDF)

Paired Analysis from Patients with Myeloma Elucidates Favorable CAR-T Manufacture and Phenotype, Starting from Mobilized Pre-Transplant Apheresis Vs. Non-Mobilized Apheresis after Four Prior Lines

Blood, 2023-11, Vol.142 (Supplement 1), p.1931-1931

2023

Volltextzugriff (PDF)

Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e20055-e20055

2023

Volltextzugriff (PDF)

Will adding alkylating agent to bortezomib improve survival of newly diagnosed AL amyloidosis patients?

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.8517-8517

2020

Volltextzugriff (PDF)

Impact of doxycycline on outcomes in AL amyloidosis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e20568-e20568

2020

Volltextzugriff (PDF)

Clinical presentation and outcome of patients with AL amyloidosis requiring salvage therapy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e20043-e20043

2021

Volltextzugriff (PDF)

Updated Outcomes of Fludarabine/Melphalan/Bortezomib (Flu/Mel/Vel) Conditioning for Upfront Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

Blood, 2016-12, Vol.128 (22), p.5885-5885

2016

Volltextzugriff (PDF)

Reflex sympathetic dystrophy

Neurology, 1995-06, Vol.45 (6), p.1236-1237

1995

Volltextzugriff (PDF)

Cytogenetics and Clinical Outcomes of Plasma Cell Leukemia Patients: A Single Institution Experience

Blood, 2009-11, Vol.114 (22), p.4932-4932

2009

Volltextzugriff (PDF)

Phase I Study of Bortezomib(Bz), Pegylated Doxorubicin(DOX) and Dexamethasone(dex); ( VDD) with Escalating Doses of Cyclophosphamide(Cy) in Patients with Newly Diagnosed Myeloma

Blood, 2009-11, Vol.114 (22), p.617-617

2009

Volltextzugriff (PDF)

A Phase 2 Study of High-Dose Melphalan Plus Bortezomib (Mel/Vel) Conditioning Followed By Autologous Hematopoietic Cell Transplantation in Myeloma

Blood, 2014-12, Vol.124 (21), p.3987-3987

2014

Volltextzugriff (PDF)

Allogeneic Hematopoietic Cell Transplantation Using Fludarabine, Melphalan and Bortezomib (Flu/Mel/Vel) Conditioning For Consolidation Of VGPR Or CR In Myeloma

Blood, 2013-11, Vol.122 (21), p.3390-3390

2013

Volltextzugriff (PDF)

Outcomes of patients with solitary plasmacytomas (SP) in the era of PET imaging and serum-free light chain (sFLC) testing: A single institution experience

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8608-8608

2013

Volltextzugriff (PDF)

Prolonged Sirolimus Administration after Matched Related and Unrelated Allogeneic Hematopoietic Cell Transplantation Is Associated with Decreased Risk for Moderate-Severe Chronic Graft Vs. Host Disease

Blood, 2014-12, Vol.124 (21), p.2502-2502

2014

Volltextzugriff (PDF)

Does HLA-C Matching Predict the Engrafting Unit in Double Umbilical Cord Blood Transplants?: A Single Institution Retrospective Analysis

Blood, 2014-12, Vol.124 (21), p.2475-2475

2014

Volltextzugriff (PDF)

Beclomethasone and Budesonide Are Partially Effective As Sole Therapy for Isolated Gastro-Intestinal Gvhd

Blood, 2014-12, Vol.124 (21), p.2500-2500

2014

Volltextzugriff (PDF)

Apheresis of Hematopoietic Progenitor Cell (HPC) From Allogeneic Donors ≥60 Years of Age

Blood, 2009-11, Vol.114 (22), p.4226-4226

2009

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(119)
Tagungsberichte
(1)

Sprache

Englisch
(120)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Mechanical hyperalgesias in neuropathic pain patients: Dynamic and static subtypes

Neuropathic pain: redefinition and a grading system for clinical and research purposes

'Sympathetically maintained pain.' I. Phentolamine block questions the concept

Phentolamine sympathetic block in painful polyneuropathies. II. Further questioning of the concept of 'sympathetically maintained pain'

Reversal of hypoaesthesia by nerve block, or placebo: a psychologically mediated sign in chronic pseudoneuropathic pain patients

Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors

Teclistamab Induces Favorable Responses in Patients with Relapsed and Refractory Multiple Myeloma after Prior BCMA-Directed Therapy

Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning Results in Favorable Outcomes with Haploidentical Donor Peripheral Blood Stem Cell Transplant

Post-Transplant Cyclophosphamide Equalizes Clinical Outcomes of Allogeneic Hematopoietic Cell Transplantation across Racial and Ethnic Populations

Paired Analysis from Patients with Myeloma Elucidates Favorable CAR-T Manufacture and Phenotype, Starting from Mobilized Pre-Transplant Apheresis Vs. Non-Mobilized Apheresis after Four Prior Lines

Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience

Will adding alkylating agent to bortezomib improve survival of newly diagnosed AL amyloidosis patients?

Impact of doxycycline on outcomes in AL amyloidosis

Clinical presentation and outcome of patients with AL amyloidosis requiring salvage therapy

Updated Outcomes of Fludarabine/Melphalan/Bortezomib (Flu/Mel/Vel) Conditioning for Upfront Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

Reflex sympathetic dystrophy

Cytogenetics and Clinical Outcomes of Plasma Cell Leukemia Patients: A Single Institution Experience

Phase I Study of Bortezomib(Bz), Pegylated Doxorubicin(DOX) and Dexamethasone(dex); ( VDD) with Escalating Doses of Cyclophosphamide(Cy) in Patients with Newly Diagnosed Myeloma

A Phase 2 Study of High-Dose Melphalan Plus Bortezomib (Mel/Vel) Conditioning Followed By Autologous Hematopoietic Cell Transplantation in Myeloma

Allogeneic Hematopoietic Cell Transplantation Using Fludarabine, Melphalan and Bortezomib (Flu/Mel/Vel) Conditioning For Consolidation Of VGPR Or CR In Myeloma

Outcomes of patients with solitary plasmacytomas (SP) in the era of PET imaging and serum-free light chain (sFLC) testing: A single institution experience

Prolonged Sirolimus Administration after Matched Related and Unrelated Allogeneic Hematopoietic Cell Transplantation Is Associated with Decreased Risk for Moderate-Severe Chronic Graft Vs. Host Disease

Does HLA-C Matching Predict the Engrafting Unit in Double Umbilical Cord Blood Transplants?: A Single Institution Retrospective Analysis

Beclomethasone and Budesonide Are Partially Effective As Sole Therapy for Isolated Gastro-Intestinal Gvhd

Apheresis of Hematopoietic Progenitor Cell (HPC) From Allogeneic Donors ≥60 Years of Age

Aktive Filter

Suchergebnisse filtern